Hongjun Jin Selected Research

N- (2- chloro- 3- (trifluoromethyl)benzyl)- N- methyl- 5- oxopyrrolidine- 2- carboxamide

5/2017

Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongjun Jin Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 08/2011
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 01/2016
6	Leukemia 01/2019 - 01/2016
4	Inflammation (Inflammations) 01/2018 - 02/2012
3	Infections 01/2021 - 02/2010
3	Alzheimer Disease (Alzheimer's Disease) 02/2018 - 02/2016
3	Multiple Sclerosis 01/2018 - 10/2016
3	Dementia (Dementias) 01/2018 - 04/2015
3	Breast Neoplasms (Breast Cancer) 01/2013 - 11/2009
2	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 01/2019
2	Esophageal Squamous Cell Carcinoma 07/2021 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2020
2	Neuroinflammatory Diseases 02/2018 - 05/2017
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 05/2017
2	Carcinoma (Carcinomatosis) 08/2013 - 08/2011
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Nasopharyngeal Carcinoma 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Triple Negative Breast Neoplasms 09/2020
1	Phototoxic Dermatitis (Phototoxicity) 09/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Tauopathies 02/2018
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Atherosclerosis 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Neointima 01/2017
1	Hyperplasia 01/2017
1	Vascular System Injuries 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016
1	Parkinson Disease (Parkinson's Disease) 02/2016
1	Central Nervous System Diseases (CNS Diseases) 08/2015
1	Asthma (Bronchial Asthma) 01/2014
1	Respiratory Hypersensitivity 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 10/2013
1	Breast Diseases (Breast Disease) 01/2013

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 09/2021 - 11/2009
8	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2009
7	NucleophosminIBA 01/2019 - 01/2016
5	Cholinergic Agents (Cholinergics)IBA 01/2018 - 04/2015
5	Sphingosine-1-Phosphate ReceptorsIBA 01/2018 - 08/2015
3	Small Interfering RNA (siRNA)IBA 01/2019 - 08/2011
3	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 01/2018 - 04/2015
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2020
2	EnzymesIBA 01/2019 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2014
2	Purinergic P2X7 ReceptorsIBA 02/2018 - 05/2017
2	Blood Proteins (Serum Proteins)IBA 01/2013 - 09/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Peptides (Polypeptides)IBA 09/2021
1	LY2510924IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2021
1	CXC ChemokinesIBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2020
1	Adenosine Monophosphate (AMP)IBA 09/2020
1	AcidsIBA 09/2020
1	Metformin (Glucophage)FDA LinkGeneric 09/2020
1	Oxygen (Dioxygen)IBA 09/2020
1	heme aIBA 09/2020
1	Protein Kinases (Protein Kinase)IBA 09/2020
1	NucleotidesIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	CPG-oligonucleotideIBA 10/2019
1	Pyruvate KinaseIBA 01/2019
1	VimentinIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	IsoenzymesIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 11/2018
1	TZ6019IBA 02/2018
1	phosphatidylinositol-3,4-bisphosphate 4-phosphataseIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	LipopolysaccharidesIBA 05/2017
1	salicylhydroxamic acid (SHAM)IBA 05/2017
1	ElementsIBA 05/2017
1	N- (2- chloro- 3- (trifluoromethyl)benzyl)- N- methyl- 5- oxopyrrolidine- 2- carboxamideIBA 05/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	mepolizumabIBA 01/2014
1	ImmunosorbentsIBA 01/2014
1	Chemokine CCL5IBA 01/2014
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2013
1	Monoclonal AntibodiesIBA 10/2013
1	NF-kappa B (NF-kB)IBA 08/2013
1	bcl-X ProteinIBA 08/2013
1	Ceruloplasmin (Ferroxidase)IBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012
1	Reactive Nitrogen SpeciesIBA 02/2012
1	RNA (Ribonucleic Acid)IBA 01/2012

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
1	Radiotherapy 01/2022
1	Boron Neutron Capture Therapy 01/2022
1	Neoadjuvant Therapy 01/2021
1	Photochemotherapy (Photodynamic Therapy) 09/2020
1	Intravenous Injections 11/2018
1	Induction Chemotherapy 01/2016